Researchers say nicotinamide adenine dinucleotide (NAD+) has real biological importance — but the consumer hype around pills, injections and IV drips has far outpaced the science.
Why people are excited
NAD+ is a vital molecule involved in cellular energy production, DNA repair and other processes that decline with age. Because levels of NAD+ fall as people get older, scientists think boosting it might help delay or reduce some age-related problems. That idea has made NAD+ a popular target in longevity research and the wellness industry, and has attracted celebrities, biohackers and a thriving market of products and clinics.
What’s being claimed
Marketing for NAD+ treatments promises benefits ranging from increased energy and clearer thinking to slower aging, better recovery and improved sleep. Clinics often describe NAD+ as a “cellular” or “mitochondrial” tonic that repairs damage and restores youthful function.
What the science actually shows
– Strong preclinical data: Many animal studies, especially in mice and other rodents, show impressive effects — improved mitochondrial function, greater strength and exercise capacity, reduced inflammation and better metabolic measures.
– Humans: The human evidence is still limited. Most clinical work has tested NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), rather than NAD+ itself. Small trials have reported promising results in specific groups (for example, people with prediabetes, early Parkinson’s or peripheral artery disease), but larger, well-controlled studies have often failed to reproduce the dramatic benefits seen in animals.
– Pharmacology: Oral NAD+ is likely to be broken down in the gut and not absorbed well. That’s why researchers focus on oral precursors (NR, NMN), which can raise blood NAD+ levels after weeks of supplementation. Early data suggest blood levels can be increased safely, but whether that reliably translates into improved cellular function and lasting health benefits remains unproven.
Marketplace reality
– Product types: Consumers can buy over-the-counter NAD+ pills, precursor supplements (NR/NMN), injectable kits, and IV infusion sessions. Prices range widely: pills can cost $30–$80 or more, injections several hundred dollars, and single IV sessions commonly $200–$1,000 or higher.
– Misalignment with research: Many products and service offerings aren’t backed by rigorous clinical evidence. Direct NAD+ oral supplements are sold despite poor absorption; injectables and IV infusions are popular but have little published, well-controlled human data to show clinical benefit.
– Industry voices: Some people working in the wellness sector argue that signals from users and ongoing research should not be dismissed, while academic researchers caution that enthusiasm risks getting ahead of rigorous trials.
Safety and unknowns
– Short-term safety: Trials of NR and NMN in humans have generally reported good short-term safety profiles. Small studies testing infusions or injections report that the procedures can be tolerated but sometimes cause unpleasant side effects.
– Adverse effects: Reports from small infusion studies include moderate to severe abdominal cramping, diarrhea, nausea and vomiting in some participants.
– Long-term risks: Some animal models have raised theoretical concerns — for example, the possibility that raising NAD+ might promote tumor growth under certain conditions — but this has not been widely observed and long-term human data are lacking. Without multi-year trials, long-term safety and rare risks remain uncertain.
– Quality control: Independent testing of supplements has found variability in quality and discrepancies between label claims and actual contents. That increases the risk that consumers don’t get what they expect.
What to make of it
There is a plausible biological rationale and encouraging early data for NAD+ biology, but the current consumer market is ahead of conclusive human evidence. For most people, spending large sums on NAD+ injections or pricey IV drips is unlikely to be justified by current science. Some precursors have shown they can raise blood NAD+ levels and appear safe in short-term studies, but clear, replicated health benefits in broad populations have not yet been demonstrated.
Practical advice
– Talk with your clinician before starting NAD+ products, especially if you have chronic conditions or take other medications.
– Be skeptical of bold claims marketing NAD+ as a universal cure or fountain of youth.
– If you try supplements, choose products that have been independently tested and follow recommended dosages from trials rather than dramatic, unvalidated regimens.
– Watch for ongoing research: large, well-controlled human trials are underway and will be critical to determining whether NAD+ targeting is a safe and effective strategy for improving aging-related outcomes.
Bottom line
NAD+ is scientifically interesting and worth continued study. But at present, commercially available NAD+ pills, shots and IV drips are not proven to deliver broad longevity or anti-aging benefits for the average person. Proceed cautiously, consult a medical professional, and wait for larger clinical trials to clarify who — if anyone — truly benefits.